Seattle Genetics Reports Third Quarter 2018 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. LVS
6. SAP
7. CSX
8. LRCX
9. SPY
10. KNX

Go back to Seattle Genetics Reports Third Quarter 2018 Financial Results

Seattle Genetics (SGEN) PT Lowered to $92 at RBC Capital

October 26, 2018 7:35 AM EDT

RBC Capital analyst Kennen MacKay lowered the price target on Seattle Genetics (NASDAQ: SGEN) to $92.00 (from $98.00) while maintaining a Outperform rating.

The analyst notes the surprise Adcetris miss brings questions to 1L HL aspect of bull thesis.

... More

Seattle Genetics (SGEN) Sinks Following Q3 Results, Q4 Outlook

October 25, 2018 5:40 PM EDT

Seattle Genetics (NASDAQ: SGEN) is down 16% after-hours after the company reported Q3 EPS of ($0.34), $0.07 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $169.4 million versus the consensus estimate of $166.92 million.

The company sees Q4 ADCETRIS net product sales of $128-$133 million and FY 2018 ADCETRIS net product sales of $473-$478 million.

ADCETRIS... More